STAT3 and ovarian carcinoma: GSNO attenuates STAT3 and Akt phosphorylation induced by growth factor and reduces the basal level of their phosphorylation forms [59], suggesting that GSNO may inhibit cell proliferation by regulating the growth factor-induced signaling pathway in ovarian cancer cells.